MétaCan
Menu
Back to cohort
Record W2906577345 · doi:10.5114/pg.2018.79815

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease

2018· article· en· W2906577345 on OpenAlexaboutno aff
Dimitrios Patoulias, Maria Kalogirou

Bibliographic record

VenueGastroenterology Review · 2018
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsEmpagliflozinFatty liverMedicineType 2 diabetesInternal medicineLiver diseaseDiabetes mellitusAlcoholic liver diseaseBridge (graph theory)SteatohepatitisDiseaseGastroenterologyEndocrinologyCirrhosis

Abstract

fetched live from OpenAlex

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Patoulias D, Kalogirou M. Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2018;13(4):337-339. doi:10.5114/pg.2018.79815. APA Patoulias, D., & Kalogirou, M. (2018). Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 13(4), 337-339. https://doi.org/10.5114/pg.2018.79815 Chicago Patoulias, Dimitrios, and Maria Kalogirou. 2018. "Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease". Gastroenterology Review/Przegląd Gastroenterologiczny 13 (4): 337-339. doi:10.5114/pg.2018.79815. Harvard Patoulias, D., and Kalogirou, M. (2018). Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 13(4), pp.337-339. https://doi.org/10.5114/pg.2018.79815 MLA Patoulias, Dimitrios et al. "Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 13, no. 4, 2018, pp. 337-339. doi:10.5114/pg.2018.79815. Vancouver Patoulias D, Kalogirou M. Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2018;13(4):337-339. doi:10.5114/pg.2018.79815.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.125
Threshold uncertainty score0.762

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.293
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueGastroenterology ReviewSame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207